Ocular complications of antineoplastic therapies.
antineoplastic agents
cancer
chemotherapy
ophthalmic side effects
Journal
Future science OA
ISSN: 2056-5623
Titre abrégé: Future Sci OA
Pays: England
ID NLM: 101665030
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
05
12
2022
accepted:
15
05
2023
medline:
24
7
2023
pubmed:
24
7
2023
entrez:
24
7
2023
Statut:
epublish
Résumé
Ocular complications of antineoplastic agents can have a profound effect on the quality of life of cancer patients. New oncologic treatments like monoclonal antibodies, immunotherapies, antibody-drug conjugates, checkpoint inhibitors and growth factor receptors have resulted in increased ocular complications. These ocular complications differs in respect to distinct mechanisms of actions and lead to significant challenges in the management of cancer patients. In this review, we reviewed literature, clinical studies and cases detailing ocular complications due to administration of antineoplastic agents and emphasized the need for communication between oncologists and ophthalmologists toward early detection and management of ocular complications. Ocular side effects can have a large impact on the quality of life on patients with cancer. New ways to treat cancer greatly increased patient prognosis, however, it has also resulted in increased ocular complications. This paper aims to review past medical literature, clinical studies, and case reports to describe the types of ocular complications that may arise from administration of antineoplastic agents. This paper emphasizes the need for communication between oncologists and ophthalmologists toward early detection and management for better patient care.
Autres résumés
Type: plain-language-summary
(eng)
Ocular side effects can have a large impact on the quality of life on patients with cancer. New ways to treat cancer greatly increased patient prognosis, however, it has also resulted in increased ocular complications. This paper aims to review past medical literature, clinical studies, and case reports to describe the types of ocular complications that may arise from administration of antineoplastic agents. This paper emphasizes the need for communication between oncologists and ophthalmologists toward early detection and management for better patient care.
Identifiants
pubmed: 37485446
doi: 10.2144/fsoa-2022-0081
pmc: PMC10357395
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
FSO871Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Références
Acta Neurol Scand. 1997 Oct;96(4):260-1
pubmed: 9325480
Case Rep Ophthalmol. 2018 Apr 24;9(1):254-256
pubmed: 30111992
Cornea. 2008 Jun;27(5):612-4
pubmed: 18520515
Oncotarget. 2017 May 5;8(35):58709-58727
pubmed: 28938590
Front Oncol. 2021 May 11;11:678634
pubmed: 34046363
Pharmacol Res. 2017 Mar;117:343-356
pubmed: 28077299
Clin Ophthalmol. 2010 May 14;4:427-31
pubmed: 20505834
Gynecol Oncol. 1981 Oct;12(2 Pt 1):253-5
pubmed: 7197656
Clin Cancer Res. 2020 Oct 1;26(19):5102-5112
pubmed: 32669376
Clin Exp Optom. 2023 Jul;106(5):560-563
pubmed: 35793865
PLoS One. 2020 Apr 21;15(4):e0231877
pubmed: 32315352
Cancer Chemother Pharmacol. 2016 Jun;77(6):1157-64
pubmed: 27071922
Molecules. 2017 Sep 26;22(10):
pubmed: 28954413
Case Rep Ophthalmol. 2021 Jun 21;12(2):574-577
pubmed: 34248594
Arch Ophthalmol. 1992 Aug;110(8):1150-4
pubmed: 1386726
Drugs. 2003;63(19):2127-56
pubmed: 12962525
Molecules. 2008 Aug 05;13(8):1551-69
pubmed: 18794772
Int J Med Sci. 2004;1(2):101-115
pubmed: 15912202
Front Oncol. 2019 Sep 23;9:944
pubmed: 31608234
Semin Oncol. 2017 Dec;44(6):377-380
pubmed: 29935898
Arch Ophthalmol. 2003 Aug;121(8):1120-4
pubmed: 12912689
Best Pract Res Clin Haematol. 2003 Mar;16(1):91-9
pubmed: 12670468
Am J Ophthalmol. 2006 Jan;141(1):196-7
pubmed: 16387001
Aust N Z J Med. 1979 Apr;9(2):143-4
pubmed: 287454
Turk J Ophthalmol. 2021 Apr 29;51(2):114-117
pubmed: 33951900
Cancer. 1992 Jun 15;69(12):2961-4
pubmed: 1591689
Cancer. 1996 Oct 1;78(7):1359-73
pubmed: 8839540
Oncol Nurs Forum. 2016 Mar;43(2):235-43
pubmed: 26906134
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1771-1781
pubmed: 31098752
Cancer Chemother Pharmacol. 1987;20(4):349
pubmed: 3690810
Biochem Pharmacol. 1999 Nov 15;58(10):1625-9
pubmed: 10535754
Cancer. 1988 Jan 1;61(1):33-5
pubmed: 3334951
Blood. 2018 Jul 26;132(4):393-404
pubmed: 29567798
N Engl J Med. 2019 Jul 25;381(4):338-348
pubmed: 31340094
Cancer J. 2019 Nov/Dec;25(6):386-393
pubmed: 31764119
BMC Ophthalmol. 2020 Jan 9;20(1):19
pubmed: 31918686
J Nucleic Acids. 2010 Nov 21;2010:543531
pubmed: 21113301
Dermatol Res Pract. 2014;2014:734249
pubmed: 24723942
Cancer. 1982 May 15;49(10):1999-2002
pubmed: 7074524
Scientifica (Cairo). 2013;2013:857519
pubmed: 24278787
BMJ Open Ophthalmol. 2020 Jan 07;5(1):e000331
pubmed: 32154367
Ann Oncol. 1993 Apr;4(4):337-8
pubmed: 8518227
Br J Clin Pharmacol. 2009 Oct;68(4):482-3
pubmed: 19843050
J Clin Neuroophthalmol. 1981 Dec;1(4):261-4
pubmed: 6213670
Med Pediatr Oncol. 1978;5(1):245-7
pubmed: 745590
Cancer Discov. 2018 Sep;8(9):1069-1086
pubmed: 30115704
N Engl J Med. 2014 Jul 17;371(3):213-23
pubmed: 24881631
Cancer. 1977 Jan;39(1):58-61
pubmed: 264409
Doc Ophthalmol. 1995;90(1):1-6
pubmed: 8549238
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):e109-12
pubmed: 27349766
Optom Vis Sci. 2015 May;92(5):e110-3
pubmed: 25822016
Gan To Kagaku Ryoho. 1992 Mar;19(3):409-20
pubmed: 1543370
Anticancer Drugs. 2002 Nov;13 Suppl 2:S3-10
pubmed: 12710585
J Natl Cancer Inst. 1994 Jul 20;86(14):1099-101
pubmed: 7912737
Eye (Lond). 2015 Aug;29(8):1003-12
pubmed: 26043707
J Oncol Pharm Pract. 2020 Mar;26(2):511-516
pubmed: 31735134
Trans Am Ophthalmol Soc. 1960;58:95-104
pubmed: 13683174
Cancers (Basel). 2020 Jul 07;12(7):
pubmed: 32645969
Invest Ophthalmol Vis Sci. 1985 Apr;26(4):580-3
pubmed: 3980172
Aust Prescr. 2016 Aug;39(4):131-134
pubmed: 27756976
J Oncol Pharm Pract. 2022 Apr;28(3):725-728
pubmed: 34775854
Ann Ophthalmol. 1981 Jun;13(6):709-11
pubmed: 7020552
BMC Ophthalmol. 2019 May 14;19(1):110
pubmed: 31088416
J Cancer Sci Ther. 2019;11(4):
pubmed: 32148661
Retina. 2019 Aug;39(8):1435-1450
pubmed: 30681641
Leuk Res. 2010 Oct;34(10):1255-68
pubmed: 20537386
Arch Ophthalmol. 1982 Nov;100(11):1766-72
pubmed: 7138345
Br J Ophthalmol. 2023 Jul;107(7):901-905
pubmed: 35144919
J Clin Oncol. 1983 Jun;1(6):392-3
pubmed: 6199475
Future Oncol. 2019 Jun;15(16):1939-1945
pubmed: 31140869
Cancer. 1991 Oct 15;68(8):1691-3
pubmed: 1913509
N Engl J Med. 2000 Sep 7;343(10):740-1
pubmed: 10979776
Eye Contact Lens. 2003 Apr;29(2):134-5
pubmed: 12695719
Ophthalmology. 1986 Nov;93(11):1471-5
pubmed: 3808609
Int J Retina Vitreous. 2021 Apr 23;7(1):34
pubmed: 33892812
Am J Ophthalmol. 2014 Oct;158(4):831-837.e2
pubmed: 25036880
Cancer Treat Rep. 1986 Oct;70(10):1225-8
pubmed: 2428492
Case Rep Ophthalmol. 2016 Feb 04;7(1):74-8
pubmed: 26933433
Bone Marrow Transplant. 1999 Oct;24(7):785-92
pubmed: 10516683
Onco Targets Ther. 2014 Jul 31;7:1361-6
pubmed: 25114574
Blood Cancer J. 2021 Dec 7;11(12):196
pubmed: 34876555
Chemother Res Pract. 2014;2014:357027
pubmed: 24963404
J Clin Oncol. 2000 Jan;18(2):317-24
pubmed: 10637245
Ann Oncol. 2016 Jun;27(6):998-1005
pubmed: 26951625
Aust Prescr. 2021 Aug;44(4):129-136
pubmed: 34421178
Ocul Immunol Inflamm. 2022 May 19;30(4):1005-1008
pubmed: 33539715
Mol Cancer. 2018 Feb 19;17(1):36
pubmed: 29455664
Clin Cancer Res. 2008 Mar 1;14(5):1296-302
pubmed: 18316547
J Ocul Pharmacol Ther. 2003 Aug;19(4):371-5
pubmed: 12964961
Cancer. 1983 Feb 1;51(3):430-2
pubmed: 6571799
Arch Pharm Res. 2019 Jul;42(7):607-616
pubmed: 30830661
Clin Oncol (R Coll Radiol). 2001;13(6):438-40
pubmed: 11824881
Eur J Ophthalmol. 2022 Jul;32(4):NP94-NP97
pubmed: 33719653
Ophthalmic Plast Reconstr Surg. 2003 May;19(3):216-24
pubmed: 12918558
Oncotarget. 2019 Jan 29;10(9):1011-1013
pubmed: 30847029
Cancer. 1979 Jul;44(1):69-71
pubmed: 455266
J Clin Oncol. 1985 Dec;3(12):1683-9
pubmed: 4067616
Ann Oncol. 2014 Jul;25(7):1437-1441
pubmed: 24864047
Retina. 2018 Jun;38(6):1063-1078
pubmed: 29689030
Drugs. 2013 Jul;73(11):1245-54
pubmed: 23846731
JOP. 2008 Mar 08;9(2):216-9
pubmed: 18326933
Curr Pharm Des. 1999 Aug;5(8):555-60
pubmed: 10469891
BMC Ophthalmol. 2017 Aug 17;17(1):146
pubmed: 28818062